These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 16027809)

  • 41. Simvastatin preserves myocardial perfusion and coronary microvascular permeability in experimental hypercholesterolemia independent of lipid lowering.
    Bonetti PO; Wilson SH; Rodriguez-Porcel M; Holmes DR; Lerman LO; Lerman A
    J Am Coll Cardiol; 2002 Aug; 40(3):546-54. PubMed ID: 12142124
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical investigation on the hypolipidemic effect of simvastatin in primary hypercholesterolemia.
    Saba P; Galeone F; Giuntoli F; Spagnolo G; Brunelleschi G; Lamanna F; Angelé B
    Clin Ter; 1992 Jan; 140(1 Pt 2):3-9. PubMed ID: 1559319
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Drug treatment for hypercholesterolaemia.
    Ball MJ; Mann JI
    Q J Med; 1986 Aug; 60(232):733-5. PubMed ID: 3774956
    [No Abstract]   [Full Text] [Related]  

  • 44. High-dose simvastatin exhibits enhanced lipid-lowering effects relative to simvastatin/ezetimibe combination therapy.
    Snowden SG; Grapov D; Settergren M; D'Alexandri FL; Haeggström JZ; Fiehn O; Hyötyläinen T; Pedersen TL; Newman JW; Orešič M; Pernow J; Wheelock CE
    Circ Cardiovasc Genet; 2014 Dec; 7(6):955-964. PubMed ID: 25516625
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Simvastatin and asymmetric dimethylarginine-homocysteine metabolic pathways in patients with newly detected severe hypercholesterolemia.
    Vladimirova-Kitova LG; Deneva TI
    Clin Lab; 2010; 56(7-8):291-302. PubMed ID: 20857893
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy of simvastatin and ezetimibe in treating hypercholesterolemia.
    Davidson MH
    J Am Coll Cardiol; 2003 Jul; 42(2):398-9; author reply 399. PubMed ID: 12875794
    [No Abstract]   [Full Text] [Related]  

  • 47. Evaluation of simvastatin antioxidant effects.
    Ungureanu D; Filip C; Artenie A; Artenie R
    Rev Med Chir Soc Med Nat Iasi; 2003; 107(1):66-71. PubMed ID: 14755972
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of rosuvastatin with atorvastatin, simvastatin and pravastatin in achieving cholesterol goals and improving plasma lipids in hypercholesterolaemic patients with or without the metabolic syndrome in the MERCURY I trial.
    Stender S; Schuster H; Barter P; Watkins C; Kallend D;
    Diabetes Obes Metab; 2005 Jul; 7(4):430-8. PubMed ID: 15955130
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [New combination therapy. Up to 60% lower LDL cholesterol level].
    MMW Fortschr Med; 2004 May; 146(19):63. PubMed ID: 15357489
    [No Abstract]   [Full Text] [Related]  

  • 50. Prevention of cardiovascular disease: the Scandinavian experience.
    Pedersen TR
    Aging (Milano); 1998 Apr; 10(2):167. PubMed ID: 9666222
    [No Abstract]   [Full Text] [Related]  

  • 51. Safety and efficacy of ezetimibe/simvastatin combination versus atorvastatin alone in adults ≥65 years of age with hypercholesterolemia and with or at moderately high/high risk for coronary heart disease (the VYTELD study).
    Foody JM; Brown WV; Zieve F; Adewale AJ; Flaim D; Lowe RS; Jones-Burton C; Tershakovec AM
    Am J Cardiol; 2010 Nov; 106(9):1255-63. PubMed ID: 21029821
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Efficacy and tolerability of simvastatin and omega-3 fatty acid combination in patients with coronary disease, hypercholesterolemia and hypertriglyceridemia].
    Tomei R; Rossi L; Carbonieri E; Franceschini L; Cemin C; Ghebremariam-Tesfau K; Zardini P
    Cardiologia; 1993 Dec; 38(12):773-8. PubMed ID: 8200011
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Beneficial effect of simvastatin treatment on LDL oxidation and antioxidant protection is more pronounced in combined hyperlipidemia than in hypercholesterolemia.
    Molcányiová A; Stancáková A; Javorský M; Tkác I
    Pharmacol Res; 2006 Sep; 54(3):203-7. PubMed ID: 16737822
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ezetimibe + simvastatin (Merck/Schering-Plough).
    Flores NA
    Curr Opin Investig Drugs; 2004 Sep; 5(9):984-92. PubMed ID: 15503655
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Coadministration of valsartan 160 and 320 mg and simvastatin 20 and 40 mg in patients with hypertension and hypercholesterolemia: a multicenter, 12-week, double-blind, double-dummy, parallel-group superiority study.
    Rump LC; Baranova E; Okopien B; Weisskopf M; Kandra A; Ferber P
    Clin Ther; 2008 Oct; 30(10):1782-93. PubMed ID: 19014834
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Effect of simvastatin on thrombocyte functional activity in patients with ischemic heart disease and hypercholesterinemia].
    Abidova KR
    Lik Sprava; 2004; (3-4):93-7. PubMed ID: 15318838
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vitamin E in kidney transplantation: effect of treatment with simvastatin in hypercholesterolemia.
    Cantarell C; Bonal J; Sierra C; Pastor C; Lauzurica R; Capdevila L
    Transplant Proc; 1995 Aug; 27(4):2222-3. PubMed ID: 7652781
    [No Abstract]   [Full Text] [Related]  

  • 58. [The influence of ezetimibe and simvaststin on platelet aggregation and protein c system in patients with coronary heart disease and hypercholesterolemia].
    Vashchenko VI; Kozobova AI; Filippov AE; Chechetkin AV; Popova NN; Vil'ianinov VN; Vashchenko TN
    Klin Med (Mosk); 2012; 90(3):66-8. PubMed ID: 22690571
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Guidelines for lowering lipids to reduce coronary artery disease risk: a comparison of rosuvastatin with atorvastatin, pravastatin, and simvastatin for achieving lipid-lowering goals.
    Shepherd J; Hunninghake DB; Barter P; McKenney JM; Hutchinson HG
    Am J Cardiol; 2003 Mar; 91(5A):11C-17C; discussion 17C-19C. PubMed ID: 12646338
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Phospholipid content of subfractions of high density lipoproteins in women with angiographically documented coronary arteriosclerosis].
    Maĭ FT; Liakishev AA; Polesskiĭ VA; Sidorenko BA; Gerasimova EN
    Kardiologiia; 1983 Mar; 23(3):33-7. PubMed ID: 6855058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.